Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
It belongs to a class of drugs known as GLP-1 receptor agonists
doi: 10.1136/gutjnl-2024-331914 7 PaikJFierceYTreutingPMBrabbTMaggio-PriceL
reuteri can significantly increase natural GLP-1 production
Be alert to dizziness when changing positions Monitor blood pressure if possible, as dehydration can cause drops Note frequency and colour of urination throughout the day Medical considerations Adjust medication timing to minimise side effects that contribute to dehydration Consider temporary dose adjustment in consultation with your healthcare provider Discuss anti-nausea or anti-diarrhoeal medications if these symptoms are contributing to fluid loss Consider IV fluids for severe cases (requires medical intervention) When to seek medical advice Contact your healthcare provider immediately if you experience: Severe thirst that cannot be satisfied by drinking Little or no urination for 8 hours or more Dizziness or lightheadedness that impairs functioning Confusion, disorientation, or extreme fatigue Rapid heart rate or breathing Fainting or severe weakness Inability to keep fluids down due to vomiting Long-term outlook With proper management, most patients can maintain adequate hydration whilst on GLP-1 treatments
SDT-fatty rats and DS mice were euthanized by isoflurane inhalation at an overdose for prolonged time periods
